News

Is Verona Pharma Gaining or Losing Market Support?
Verona Pharma's VRNA short percent of float has fallen 11.62% since its last report. The company recently reported that it ...
Barchart on MSN2d
Up 515%, Watch This Biopharma Breakout
Verona Pharma (VRNA) is showing exceptional technical strength, hitting a new high in morning trading on June 24. ・The stock has a 100% technical “Buy” signal via Barchart. ・The stock has surged 515% ...
Verona Pharma (VRNA) Achieved Strong Launch for Ensifentrine After FDA Approval
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” ...
Roth Capital Hikes Verona Pharma’s (VRNA) Price Target to $116 On COPD Market Prospects
Verona Pharma plc (NASDAQ:VRNA) is one of the 10 biotech stocks screaming a buy. On June 17, Roth Capital increased its price ...